COMPASS Pathways acquires IP portfolio of novel psychedelic compounds and prodrugs
September 14, 2021 07:00 ET
|
COMPASS Pathfinder Ltd.
COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced that it has acquired an...
C-Bond Systems Expands Nanotechnology Product Offering for Transportation Solutions Group
March 24, 2020 08:31 ET
|
C-Bond Systems
HOUSTON, March 24, 2020 (GLOBE NEWSWIRE) -- C-Bond Systems, Inc. (the “Company” or “C-Bond”) (OTC: CBNT), a nanotechnology company that improves and strengthens glass, today announced that it has...
C-Bond Systems, Inc. Granted Key U.S. Patent Notice of Allowance Supporting Underlying Chemistry of C-Bond Core Technology
March 23, 2020 08:31 ET
|
C-Bond Systems
Patent Notice of Allowance Grants Key Claims Underlying C-Bond’s Robust Intellectual Property Portfolio, Recently Valued at $33.7 Million, to Include 22 Patents and Applications Globally C-Bond Plans...
NexTech Adds to its IP Portfolio Filing A Non-Provisional Patent Application for Augmented Reality in a Retail Environment
March 26, 2019 07:30 ET
|
NexTech AR Solutions
NEW YORK, NY and TORONTO, ON, March 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – NexTech AR Solutions (the “Company” or “NexTech”) (OTCQB: NEXCF) (CSE: NTAR) (FSE:N29) is pleased to announce that...
bioAffinity Technologies Announces Award of European Union Patent
May 03, 2017 14:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Texas, May 03, 2017 (GLOBE NEWSWIRE) -- bioAffinity Technologies announced that the European Patent Office (EPO) has issued a patent that protects the Company’s proprietary CyPath®...
Zomedica Files U.S. Provisional Patent Application for Novel Pharmaceutical Formulation
July 12, 2016 07:45 ET
|
Zomedica
ANN ARBOR, Mich., July 12, 2016 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a veterinary pharmaceutical company, today announced that it has filed a provisional application for...